Abstract:Background: The discovery of anticancer drug combinations is a crucial work of anticancer treatment. In recent years, pre-screening drug combinations with synergistic effects in a large-scale search space adopting computational methods, especially deep learning methods, is increasingly popular with researchers. Although achievements have been made to predict anticancer synergistic drug combinations based on deep learning, the application of multi-task learning in this field is relatively rare. The successful practice of multi-task learning in various fields shows that it can effectively learn multiple tasks jointly and improve the performance of all the tasks. Methods: In this paper, we propose MTLSynergy which is based on multi-task learning and deep neural networks to predict synergistic anticancer drug combinations. It simultaneously learns two crucial prediction tasks in anticancer treatment, which are synergy prediction of drug combinations and sensitivity prediction of monotherapy. And MTLSynergy integrates the classification and regression of prediction tasks into the same model. Moreover, autoencoders are employed to reduce the dimensions of input features. Results: Compared with the previous methods listed in this paper, MTLSynergy achieves the lowest mean square error of 216.47 and the highest Pearson correlation coefficient of 0.76 on the drug synergy prediction task. On the corresponding classification task, the area under the receiver operator characteristics curve and the area under the precision-recall curve are 0.90 and 0.62, respectively, which are equivalent to the comparison methods. Through the ablation study, we verify that multi-task learning and autoencoder both have a positive effect on prediction performance. In addition, the prediction results of MTLSynergy in many cases are also consistent with previous studies. Conclusion: Our study suggests that multi-task learning is significantly beneficial for both drug synergy prediction and monotherapy sensitivity prediction when combining these two tasks into one model. The ability of MTLSynergy to discover new anticancer synergistic drug combinations noteworthily outperforms other state-of-the-art methods. MTLSynergy promises to be a powerful tool to pre-screen anticancer synergistic drug combinations.

Multi-task Joint Strategies of Self-supervised Representation Learning on Biomedical Networks for Drug Discovery

Multitask joint strategies of self-supervised representation learning on biomedical networks for drug discovery

A Complete Graph-Based Approach with Multi-Task Learning for Predicting Synergistic Drug Combinations.

An In Silico Method for Predicting Drug Synergy Based on Multitask Learning

Synergistic Multi-Drug Combination Prediction Based on Heterogeneous Network Representation Learning with Contrastive Learning

Massively Multitask Networks for Drug Discovery

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

ADMET Property Prediction Via Multi-Task Graph Learning under Adaptive Auxiliary Task Selection

Uni-Dual: A Generic Unified Dual-Task Medical Self-Supervised Learning Framework

Aggregative Self-supervised Feature Learning from Limited Medical Images

Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning

Self-supervised Learning for Label Sparsity in Computational Drug Repositioning

A multi-task learning model for predicting drugs combination synergy by analyzing drug-drug interactions and integrated multi-view graph data

An Effective Multi-Task Learning Framework for Drug Repurposing Based on Graph Representation Learning.

Multi-Task Collaborative Network: Bridge the Supervised and Self-Supervised Learning for EEG Classification in RSVP Tasks

Integrating Multi-Modal Deep Learning on Knowledge Graph for the Discovery of Synergistic Drug Combinations Against Infectious Diseases

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

Heterogenous Biological Network Multi-Task Learning Model for Ncrna-Disease-drug Association Prediction

Predicting anticancer synergistic drug combinations based on multi-task learning

The Graph Convolutional Network with Multi-representation Alignment for Drug Synergy Prediction.

Multi-level Subgraph Representation Learning for Drug-Disease Association Prediction over Heterogeneous Biological Information Network.